Survival in octogenarians undergoing cardiac resynchronization therapy compared to the general population

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 6, 2014, Pages 740-744

  Rickard, John ^a   Cheng, Alan ^a   Spragg, David ^a   Green, Ariel ^a   Leff, Bruce ^a   Tang, Wilson ^b   Cantillon, Daniel ^b   Baranowski, Bryan ^b   Wilkoff, Bruce L ^b   Tchou, Patrick ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiac resynchronization therapy; elderly; octogenarians

Indexed keywords

AGE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; HEART FAILURE; LONGITUDINAL STUDY; MORTALITY; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES;

AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; OHIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84902547123     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12337     Document Type: Article

References (15)

1. McAlister FA, Tu JV, Newman A, Lee DS, Kimber S, Cujec B, Armstrong PW,. How many patients with heart failure are eligible for cardiac resynchronization therapy? Insights from two prospective cohorts. Eur Heart J 2006; 27: 323-329.
2. Task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology, ESC Committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
3. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff BL, Canby RC, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. J Am Med Assoc 2003; 289: 2685-2694.
4. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Mabo P, et al. Comparative effects of biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-1787.
5. Cleland JG, Daubert JC, Dermann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd., et al.; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
7. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, et al.; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395.
8. Swindle JP, Rich MW, Mccann P, Burroughs TE, Hauptman P,. Implantable cardiac device procedures in older patients. Arch Intern Med 2010; 170: 631-637.
9. Period Life Table 2006. Social Security Online Actuarial Publications: http://www.ssa.gov/OACT/STATS/table4c6.html (accessed August 1, 2012).
10. Verbrugge FH, Dupont M, Rivero-Ayerza M, de Vusser P, Van Herendael H, Vercammen J, Jacobs L, et al. Co-morbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling. J Card Fail 2012; 11: 845-853.
11. Achili A, Turrent F, Gasparini M, Lunati M, Sassara M, Santini M, Landolina M, et al. Efficacy of cardiac resynchronization therapy in very old patients: The Insync/Insync ICD Italian Registry. Europace 2007; 9: 732-738.
12. Verbrugge FH, Dupont M, De Vusser P, Rivero-Ayerza M, Van Herendael H, Vercammen J, Jacobs L, et al. Response to cardiac resynchronization therapy in elderly patients (> = 70 years) and octogenarians. Eur J Heart Fail 2013; 15: 203-210.
13. Killu AM, Wu JH, Friedman PA, Shen WK, Webster TL, Brooke KL, Hodge DO, et al. Outcomes of cardiac resynchronization therapy in the elderly. Pacing Clin Electrophysiol 2013; 36: 664-672.
14. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM,. Clinical response of cardiac resynchronization therapy in the elderly. Am Heart J 2008; 155: 746-751.
15. Kron J, Aranda JM, Miles WM, Burkart TA, Woo GW, Saxonhouse SJ, Sears SF, et al. Benefit of cardiac resynchronization in elderly patients: Results from the Multicenter Insync Randomized Clinical Evaluation (MIRACLE) and Multicenter Insync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. J Interv Card Electrophysiol 2009; 25: 91-96.